We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Eli Lilly
LLY
$1.08T
| $3.22M | 0.12% |
6,870
+4,270
| +164% | +$1.79M |
|
|
ODP
227
DELISTED
ODP
ODP
| $3.22M | 0.12% |
+68,756
| New | +$2.95M |
|
228
Polaris
PII
$3.83B
| $3.22M | 0.12% |
26,595
-29,552
| -53% | -$3.27M |
|
229
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$169M
| $3.18M | 0.12% |
+31,817
| New | +$4.49M |
|
230
Legend Biotech
LEGN
$3.65B
| $3.17M | 0.12% |
+45,935
| New | +$3M |
|
231
Norwegian Cruise Line
NCLH
$9.53B
| $3.15M | 0.12% |
+144,540
| New | +$2.21M |
|
232
Interactive Brokers
IBKR
$38.4B
| $3.14M | 0.12% |
151,424
-134,400
| -47% | -$2.65M |
|
233
Insulet
PODD
$11.8B
| $3.14M | 0.12% |
10,875
-9,751
| -47% | -$2.96M |
|
234
Plains All American Pipeline
PAA
$17.6B
| $3.13M | 0.12% |
+222,322
| New | +$2.94M |
|
235
Chipotle Mexican Grill
CMG
$43.9B
| $3.13M | 0.12% |
73,150
+60,550
| +481% | +$2.4M |
|
236
FMC
FMC
$1.25B
| $3.13M | 0.12% |
29,989
+23,489
| +361% | +$2.64M |
|
237
Cameco
CCJ
$36.8B
| $3.13M | 0.12% |
99,800
+89,105
| +833% | +$2.51M |
|
238
STAAR Surgical
STAA
$1.19B
| $3.12M | 0.12% |
+59,422
| New | +$3.62M |
|
239
Teradyne
TER
$50B
| $3.12M | 0.12% |
+28,030
| New | +$2.81M |
|
240
Azenta
AZTA
$1.3B
| $3.12M | 0.12% |
66,819
+4,336
| +7% | +$190K |
|
241
AngloGold Ashanti
AU
$39.4B
| $3.1M | 0.11% |
+147,154
| New | +$3.71M |
|
242
Rockwell Automation
ROK
$51.1B
| $3.08M | 0.11% |
+9,362
| New | +$2.7M |
|
243
Everest Group
EG
$15.6B
| $3.08M | 0.11% |
+9,005
| New | +$3.25M |
|
244
DexCom
DXCM
$29B
| $3.07M | 0.11% |
23,910
-6,120
| -20% | -$740K |
|
245
Sibanye-Stillwater
SBSW
$6.05B
| $3.05M | 0.11% |
489,580
+66,489
| +16% | +$524K |
|
246
Amylyx Pharmaceuticals
AMLX
$2.19B
| $3.05M | 0.11% |
+141,447
| New | +$3.82M |
|
|
AXNX
247
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.05M | 0.11% |
60,363
+1,075
| +2% | +$57.2K |
|
248
Prologis
PLD
$136B
| $3.04M | 0.11% |
+24,783
| New | +$3.05M |
|
249
Infosys
INFY
$51B
| $3.03M | 0.11% |
+188,282
| New | +$2.94M |
|
250
Chewy
CHWY
$9.54B
| $3M | 0.11% |
76,042
-62,896
| -45% | -$2.19M |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.